technology

Uncategorized

Navigating the Complexities of Biotech Patent Law: A Look at REGENXBIO v. Sarepta Therapeutics

The rapidly evolving field of biotech patent law continues to present significant challenges, particularly when it comes to innovations involving recombinant nucleic acids and biological sequences. A recent ruling in REGENXBIO v. Sarepta Therapeutics by the US District Court for the District of Delaware has brought to light critical issues regarding patent eligibility for biotechnological […]

Uncategorized

Ericsson and Lenovo Settle Patent Licensing Dispute, Arbitration to Resolve Remaining Issues

Ericsson and Lenovo have reached a settlement to partially resolve their ongoing patent licensing dispute, stemming from a multi-year, global patent cross-license agreement between the two companies. Under the terms of the settlement, all current lawsuits and administrative proceedings initiated by both parties across multiple jurisdictions, including those before the United States International Trade Commission

Uncategorized

GSK Resolves Patent Lawsuit Against Pfizer Over RSV Vaccines

Pharmaceutical giants GSK and Pfizer have reached a settlement to resolve a long-running patent dispute related to respiratory syncytial virus (RSV) vaccines. The legal battle, which revolved around patent infringement claims, has now been brought to a close through an agreement between the two companies. The lawsuit centered on allegations that Pfizer’s RSV vaccine infringed

Scroll to Top